About the Authors
- Maria Lund Nielsen
-
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Thomas Isbrandt
-
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Kasper Bøwig Rasmussen
-
Current address: Novo Nordisk A/S, Niels Steensens Vej 1, Gentofte, Denmark
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Ulf Thrane
-
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Jakob Blæsbjerg Hoof
-
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Thomas Ostenfeld Larsen
-
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
- Uffe Hasbro Mortensen
-
* E-mail: um@bio.dtu.dk
Affiliation Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens Lyngby, Denmark
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: MLN UT JBH TOL UHM. Formal analysis: MLN TI KBR. Funding acquisition: TOL. Investigation: MLN TI JBH. Writing – original draft: MLN. Writing – review & editing: MLN TI UT JBH TOL UHM.